Kemi Oluwayi
Allergy Therapeutics (United Kingdom)(GB)
Publications by Year
Research Areas
Allergic Rhinitis and Sensitization, Food Allergy and Anaphylaxis Research, Dermatology and Skin Diseases, Asthma and respiratory diseases, Transgenic Plants and Applications
Most-Cited Works
- → Short‐course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy(2023)23 cited
- → Ara h 2–expressing cucumber mosaic virus–like particle (VLP Peanut) induces in vitro tolerogenic cellular responses in peanut-allergic individuals(2025)8 cited
- → Dogmas, challenges, and promises in phase III allergen immunotherapy studies(2021)7 cited
- → Peripheral blood mononuclear cell transcriptome profile in a clinical trial with subcutaneous, grass pollen allergoid immunotherapy(2024)6 cited
- → Virus Like Particle (VLP) Based Peanut Allergen Immunotherapy Candidate Display A Decreased Activation And Histamine Release From CRTH2+ Basophils: A Proof of Concept Study(2022)1 cited
- → A Tyrosine Adsorbed Modified Grass Allergen + MPL SCIT Demonstrates Clinically Improvement in Combined Symptom and Medication Score in Subjects with Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis(2022)1 cited
- → Modulation of Cellular, Molecular, and Humoral Responses by PQ Grass 27,600 SU for the Treatment of Seasonal Allergic Rhinitis: A Randomised Double Blind Placebo Control Exploratory Field Study(2025)1 cited
- → Differential Transcriptome Immunomodulatory Profile of an Adjuvanted Modified Grass Immunotherapy in Subjects with Seasonal Allergic Rhinitis and Rhinoconjuctivitis(2023)
- → Modulation of Pro-Allergic T Cell Responses by PQ Grass 27600 SU as a Treatment for Seasonal Allergic Rhinitis: A RDBPC Pilot Study(2023)
- → Induction of Local and Systemic Blocking Antibodies by PQ Grass 27600 SU for the Treatment of Seasonal Allergic Rhinitis: A RDBPC Pilot Study(2023)